ONS-5010 (bevacizumab-vikg) Safety and Efficacy in Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration
In the prescribed treatment plan, ONS-5010 exhibited strong effectiveness in improving or stabilizing visual acuity and was also well tolerated. Bevacizumab and ranibizumab displayed a comparable safety profile. <b>[<i>Ophthalmic Surg Lasers Imaging Retina</i> 2025;56:178-189.]</b>.
Authors
- Cameron G. Javid
- Mark S. George (ORCID: https://orcid.org/0000-0003-1767-1815)
- Jennifer Kissner
- Mark S. Humayun (ORCID: https://orcid.org/0000-0002-5830-5208)
- Allen Hu
- Firas M. Rahhal
- Jeremiah Brown
- John D. Pitcher
- Terry Dagnon
Institutions
- Federal Scientific Center for Vegetable Growing (RU)
Publication Details
- Journal
- Ophthalmic surgery, lasers & imaging retina
- Published
- 2024-11-13
- DOI
- https://doi.org/10.3928/23258160-20240924-01
- Citations
- 4
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.15
Funders
- Coherus Biosciences